Form 10-Q Bellerophon Therapeutics For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Bellerophon Therapeutics (BLPH) Tops Q1 EPS by 11c
May 10, 2016 6:34 AM EDTBellerophon Therapeutics (NASDAQ: BLPH) reported Q1 EPS of ($0.54), $0.11 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
... More